
Semaglutide medicines review concluded, review of two chickenpox vaccines started

ICH guidance released for public consultation until 15 September 2025

Measures minimise risk of suicidal thoughts

Vaccine must not be used in people 65 years and above

Public consultation open until end September 2025

Seizing opportunities in a changing medicines landscape
Find medicine
What's new
FAQs
Latest news
Treatment with semaglutide should be stopped if NAION occurs

EMA concludes review of semaglutide medicines and starts review of two chickenpox vaccines
The European Medicines Agency (EMA) is closed from 18:00 on Friday 6 June until 08:30 on Tuesday 10 June

Recommendations will support better information on benefits and risks of medicines in this population

Ten new medicines recommended for approval; another four medicines recommended for extension of their therapeutic indications
Recommendations aim to optimise use and minimise development of antimicrobial resistance